Caris Life Sciences, Inc. (CAI) stock
CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30121% above fair value
$23.04−0.92 (-3.84%)
Close on Nov 13, 2026Market cap $6.51BP/E –Yield –
Caris Life Sciences statistics
87 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 10.50
- 5.80
- P/OCF Ratio
- 77.62
- 14.68
Enterprise valuationIndustry
- EV / Sales
- 6.49
- 1.67
- EV / EBIT
- 48.61
- 20.51
- EV / FCF
- 235.29
- 24.49
Share statisticsIndustry
- Shares Change (YoY)
- 164.0%
- 2.40%
- Shares Change (QoQ)
- 1.46%
- 0.33%
- Float
- 101M
- 34M
- Shares Held by Insiders
- 64.1%
- 15.4%
- Shares Held by Institutions
- 54.5%
- 83.6%
Short sellingIndustry
- Short Interest
- 11M
- –
- Short Interest Change
- -15.4%
- -0.86%
- Short % of Float
- 11.3%
- 6.28%
- Short % of Shares Outstanding
- 4.07%
- 4.21%
- Days to Cover
- 3.98
- 4.41
Stock price statisticsIndustry
- 52-Week High
- $36.50
- –
- 52-Week Low
- $14.19
- –
- 20-Day Moving Average
- $30.04
- –
- 50-Day Moving Average
- $29.39
- –
- 200-Day Moving Average
- $21.63
- –
- Average True Range (14)
- $2.19
- –
- Price Change (1 Week)
- -8.68%
- 0.23%
- Price Change (1 Month)
- -27.5%
- -0.02%
- Price Change (3 Months)
- 6.52%
- 2.13%
- Price Change (6 Months)
- 58.4%
- 17.6%
- Price Change (YTD)
- -14.6%
- 5.22%
- Price Change (1 Year)
- -6.98%
- 3.75%
- Average Volume (10 Days)
- 5M
- –
- Average Volume (20 Days)
- 4M
- –
- Average Volume (90 Days)
- 5M
- –
- Relative Volume
- 0.65
- 0.70
- Relative Strength Index (14)
- 30.9
- 46.0
- Volatility (1 Year)
- 69.7%
- 64.2%
MarginsIndustry
- Pretax Margin
- 9.31%
- 2.12%
- EBITDA Margin
- 15.5%
- 3.36%
- FCF Margin
- 2.76%
- 2.98%
Returns on capitalIndustry
- Return on Equity (ROE)
- 17.2%
- 4.82%
- Return on Assets (ROA)
- 8.58%
- -3.10%
- Return on Invested Capital (ROIC)
- 26.8%
- 4.69%
- Return on Capital Employed (ROCE)
- 12.8%
- 0.40%
Financial positionIndustry
- Current Ratio
- 6.71
- 1.41
- Quick Ratio
- 1.48
- 0.99
- Debt / Equity
- 0.61
- 0.68
- Debt / EBITDA
- 2.42
- 2.50
- Debt / FCF
- 13.60
- 4.01
- Net Debt / EBITDA
- 1.79
- 2.13
- Interest Coverage
- 3.28
- -0.63
GrowthIndustry
- Revenue Growth (YoY)
- 61.5%
- 9.63%
EfficiencyIndustry
- Asset Turnover
- 0.94
- 0.81
- Revenue Per Employee
- $567.78K
- $235.26K
- Profits Per Employee
- $52.04K
- -$5.12K
- Employee Count
- 1,846
- 910
Income statement (TTM)Industry
- Pretax Income
- $97.57M
- -$575.82K
Balance sheetIndustry
- Net Cash (Debt)
- -$291.21M
- $203.66K
- Net Cash Per Share
- -$1.03
- $0.00
- Equity (Book Value)
- $639.48M
- $235.60M
- Book Value Per Share
- $2.26
- $3.91
- Tangible Book Value
- $620.14M
- $1.59M
- Working Capital
- $908.32M
- $30.06M
Cash flow (TTM)Industry
- Capital Expenditures
- -$54.98M
- -$15.83M
- FCF Per Share
- $0.10
- $0.36
Dividends and yieldsIndustry
- Earnings Yield
- 1.48%
- 0.19%
- FCF Yield
- 0.44%
- 2.55%
- Buyback Yield
- 0.48%
- 1.01%
- Shareholder Yield
- 0.48%
- 1.58%
Taxes and interestIndustry
- Interest Expense
- $42.64M
- $7.37M
- Income Tax
- $1.51M
- $564.50K
- Effective Tax Rate
- 1.55%
- 24.1%
Scores and fair valueIndustry
- Altman Z-Score
- 5.58
- 2.24
- Piotroski F-Score
- 6
- 5
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | CAI | S&P 500 | Difference | CAI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -22.0% | -3.0% | −18.9 pts | ||
| 3 months | +3.9% | -2.8% | +6.7 pts | ||
| Year to date | -14.6% | +11.5% | −26.1 pts | ||
| 1 year | -5.2% | +13.5% | −18.6 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
11M CAI shares were sold short on Oct 30, 2026, down 15.4% from the previous report, or 11.33% of the shares available to trade. At recent volumes it would take 4.0 days to buy them back. Over the last 20 sessions, 49.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 11,494,819 | -15.4% | 2,890,330 | 4.0 |
| Oct 15, 2026 | 13,589,186 | -2.2% | 4,208,854 | 3.2 |
| Sep 30, 2026 | 13,891,975 | +4.2% | 5,592,020 | 2.5 |
| Sep 15, 2026 | 13,331,431 | -2.6% | 4,432,398 | 3.0 |
| Aug 31, 2026 | 13,684,372 | -8.5% | 5,585,958 | 2.5 |
| Aug 14, 2026 | 14,954,631 | +1.3% | 5,889,026 | 2.5 |
| Jul 31, 2026 | 14,757,565 | +25.8% | 3,505,494 | 4.2 |
| Jul 15, 2026 | 11,734,462 | -17.2% | 3,457,476 | 3.4 |
| Jun 30, 2026 | 14,175,752 | +21.8% | 3,274,799 | 4.3 |
| Jun 15, 2026 | 11,636,124 | +8.5% | 2,622,445 | 4.4 |
| May 29, 2026 | 10,729,443 | -8.7% | 2,585,339 | 4.2 |
| May 15, 2026 | 11,753,578 | -7.7% | 3,690,782 | 3.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?